glp-1 and cancer treatment Agents vs Aspirin: A New Era in Colorectal Prevention Glucagon-like peptide 1 receptor agonists

Description

not available in Louisiana or outside the United States Cancellation notice: 72 hours before next billing date, per the Refund Policy - miss it and the next cycle is billed before cancellation takes effect Refund/guarantee clarification: current Refund Policy states no guarantee of results or effectiveness Third-party rating: Trustpilot shows a TrustScore around 3.1/5 on a small number of reviews as of July 2026 - check the live count before deciding Provider review claim: usually same-day, always within 24 hours - according to VivioMD Support claim: "24/7 messaging" - according to VivioMD

Appetite suppression strengthens noticeably

You should still consult your doctor, as both medications come with their risks and side effects

Coverage for this use may vary by plan, and prior authorization is required

Typical starting doses include: Semaglutide (Wegovy): 0.25 mg weekly Tirzepatide (Zepbound): 2.5 mg weekly These starting doses were studied in programs such as the STEP and SURMOUNT trials and were gradually increased to achieve validated metabolic outcomes